Publication Date:
2017-02-25
Description:
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker Blood Cancer Journal 7, e535 (February 2017). doi:10.1038/bcj.2017.12 Authors: S S Chavan, J He, R Tytarenko, S Deshpande, P Patel, M Bailey, C K Stein, O Stephens, N Weinhold, N Petty, D Steward, L Rasche, M Bauer, C Ashby, E Peterson, S Ali, J Ross, V A Miller, P Stephens, S Thanendrarajan, C Schinke, M Zangari, F van Rhee, B Barlogie, T I Mughal, F E Davies, G J Morgan & B A Walker
Electronic ISSN:
2044-5385
Topics:
Medicine
Permalink